Cognitive interviews for measurement evaluation of the Fagerström Test for Nicotine Dependence (FTND) in smokers with schizophrenia spectrum disorders

Addictive Behaviors

Volumn 32, Issue 4, 2007, Pages 793-802

  Prochaska, Judith J ^a   Leek, Desiree N ^a   Hall, Stephen E ^a   Hall, Sharon M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Fagerstr m; Nicotine dependence; Schizophrenia; Smoking

Indexed keywords

ADULT; ARTICLE; CIGARETTE SMOKING; CLINICAL ARTICLE; COGNITION; COMMUNITY; CONTROLLED STUDY; EVALUATION; FAGERSTROM TEST FOR NICOTINE DEPENDENCE; FEMALE; HOSPITAL PATIENT; HUMAN; INSTRUMENTATION; INTERVIEW; MALE; MENTAL PATIENT; METHODOLOGY; PSYCHIATRY; QUALITATIVE ANALYSIS; SCHIZOPHRENIA; SCORING SYSTEM; SMOKING; SMOKING CESSATION;

ADULT; COGNITION; DIAGNOSIS, DUAL (PSYCHIATRY); FEMALE; HUMANS; MALE; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; REPRODUCIBILITY OF RESULTS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SMOKING;

EID: 33846359565     PISSN: 03064603     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.addbeh.2006.06.016     Document Type: Article

References (26)

1. American Psychiatric Association. Diagnostic criteria from DSM-IV (1994), Author, Washington, D.C.
2. American Psychiatric Association. Handbook of Psychiatric Measures (2002), The American Psychiatric Association, Washington, D.C. 465-467
3. Bilder R.M., Goldman R.S., Robinson D., Reiter G., Bell L., Bates J.A., et al. Neuropsychology of first-episode schizophrenia: Initial characterization and clinical correlates. American Journal of Psychiatry 157 (2000) 549-559
4. Brown R.A., Kahler C.W., Niaura R., Abrams D.B., Sales S.D., Ramsey S.E., et al. Cognitive-behavioral treatment for depression in smoking cessation. Journal of Consulting and Clinical Psychology 69 (2001) 471-480
5. Dalack G.W., Healy D.J., and Meador-Woodruff J.H. Nicotine dependence in schizophrenia: Clinical phenomena and laboratory findings. American Journal of Psychiatry 155 (1998) 1490-1501
6. DiClemente C.C., Prochaska J.O., Fairhurst S.K., Velicer W.F., Velasquez M.M., and Rossi J.S. The process of smoking cessation: An analysis of precontemplation, contemplation, and preparation stages of change. Journal of Consulting and Clinical Psychology 59 (1991) 295-304
7. El-Guebaly N., Cathcart J., Currie S., Brown D., and Gloster S. Smoking cessation approaches for persons with mental illness or addictive disorders. Psychiatric Services 53 (2002) 1166-1170
8. Etter J.F., Duc T.V., and Perneger T.V. Validity of the Fagerström Test for Nicotine Dependence and of the heaviness of smoking index among relatively light smokers. Addiction 94 (1999) 269-281
9. Goff D.C., Sullivan L.M., McEvoy J.P., Meyer J.M., Nasrallah H.A., Daumit G.L., et al. A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls. Schizophrenia Research 80 (2005) 45-53
10. Haddock C.K., Lando H., Klesges R.C., Talcott G.W., and Renaud E.A. A study of the psychometric and predictive properties of the Fagerström Test for Nicotine Dependence in a population of young smokers. Nicotine and Tobacco Research 1 (1999) 59-66
11. Hall S.M., Reus V.I., Munoz R.F., Sees K.L., Humfleet G., Hartz D.T., et al. Nortriptyline and cognitive-behavioral therapy in the treatment of cigarette smoking. Archives of General Psychiatry 55 (1998) 683-690
12. Heatherton T.F., Kozlowski L.T., Frecker R.C., and Fagerström K.O. The Fagerström Test for Nicotine Dependence: A revision of the Fagerström Tolerance Questionnaire. British Journal of Addiction 86 (1991) 1119-1127
13. Himelhoch S., Lehman A., Kreyenbuhl J., Daumit G., Brown C., and Dixon L. Prevalence of chronic obstructive pulmonary disease among those with serious mental illness. American Journal of Psychiatry 161 (2004) 2317-2319
14. Hughes J.R., Oliveto A.H., Riggs R., Kenny M., Liguori A., Pillitteri J.L., et al. Concordance of different measures of nicotine dependence: Two pilot studies. Addictive Behaviors 29 (2004) 1527-1539
15. Lichtermann D., Ekelund J., Pukkala E., Tanskanen A., and Lonnqvist J. Incidence of cancer among persons with schizophrenia and their relatives. Archives of General Psychiatry 58 (2001) 573-578
16. Patkar A.A., Gopalakrishnan R., Lundy A., Leone F.T., Certa K.M., and Weinstein S.P. Relationship between tobacco smoking and positive and negative symptoms in schizophrenia. The Journal of Nervous and Mental Disease 190 (2002) 604-610
17. Poirier M.F., Canceil O., Bayle F., Millet B., Bourdel M.C., Moatti C., et al. Prevalence of smoking in psychiatric patients. Progress in Neuropsychopharmacology and Biological Psychiatry 26 (2002) 529-537
18. Prochaska J.J., Fletcher L., Hall S.E., and Hall S.M. Return to smoking following a smoke-free psychiatric hospitalization. The American Journal on Addictions 15 (2006) 15-22
19. Shiffman S. Dynamic influences on smoking relapse process. Journal of Personality 73 (2005) 1715-1748
20. Shiffman S., Dresler C.M., Hajek P., Gilburt S.J., Targett D.A., and Strahs K.R. Efficacy of a nicotine lozenge for smoking cessation. Archives of Internal Medicine 162 (2002) 1267-1276
21. Steinberg M.L., Williams J.M., Steinberg H.R., Krejci J.A., and Ziedonis D.M. Applicability of the Fagerström Test for Nicotine Dependence in smokers with schizophrenia. Addictive Behaviors 30 (2005) 49-59
22. Steinberg M.L., Williams J.M., and Ziedonis D.M. Financial implications of cigarette smoking among individuals with schizophrenia. Tobacco Control 13 (2004) 206
23. Storr C.L., Reboussin B.A., and Anthony J.C. The Fagerström Test for Nicotine Dependence: A comparison of standard scoring and latent class analysis approaches. Drug and Alcohol Dependence 80 (2005) 241-250
24. Willis, G.B., Caspar, R.A., & Lessler, J.T. (1999). Cognitive interviewing: A "How To" Guide. (1999). Research Triangle Park, NC: Research Triangle Institute. Retrieved May 24, 2005, from National Cancer Institute Web site. http://appliedresearch.cancer.gov/areas/cognitive/interview.pdf
25. Yang Y.K., McEvoy J.P., Wilson W.H., Levin E.D., and Rose J.E. Reliabilities and intercorrelations of reported and objective measures of smoking in patients with schizophrenia. Schizophrenia Research 60 (2003) 9-12
26. Zevin S., and Benowitz N.L. Drug interactions with tobacco smoking. An update. Clinical Pharmacokinetics 36 (1999) 425-438